# FDA recall D-1247-2014

> **GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline** · Class III · drug recall initiated 2014-02-20.

## Product

Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only.  GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108.  UPC: 0-03-0766-1480-30-2.

## Reason for recall

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-1247-2014
- **Recalling firm:** GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-02-20
- **Report date:** 2014-04-30
- **Termination date:** 2017-01-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Aiken, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1247-2014

## Citation

> AI Analytics. FDA recall D-1247-2014. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-1247-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*